Last reviewed · How we verify

NCT06912945: LASER

Factors Affecting Outcomes of Using Diode Laser Both 980 nm Wave Length and 450 Wavelength on Benign Laryngeal Lesions in Comparison to Traditional Cold Instrumentations as Regard Parameters of Laser Device, Nature of Lesion and Patient Factors

ENROLLING BY INVITATION NA Last updated 24 August 2025
What this trial tests

NA trial testing using diode laser 980nm wavelength in benign laryngeal lesions in Benign Laryngeal Lesion in 108 participants. Enrolling by invitation.

Timeline
1 October 2024
Primary endpoint
31 December 2025
28 February 2026

Quick facts

Lead sponsorSohag University
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment108
Start date1 October 2024
Primary completion31 December 2025
Estimated completion28 February 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Eligibility, any sex, with Benign Laryngeal Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Studying the different Factors affecting the outcomes of using diode laser both 980 nm wave length and 450 wavelength on benign laryngeal lesions in comparison to traditional cold instrumentations

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06912945.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing